A bumper crop of orphan drugs from the likes of Amicus, Kyowa Kirin, Eusa and Biogen dominates this year’s UK Prix Galien shortlist as biotech firms and specialist pharma companies cement t
The prestigious UK Prix Galien Awards has added medical technology to its roster for the first time, recognising the burgeoning innovation in the field.
